Switzerland: BioVersys Receives €20 Million in EU Financing to Support Development of New Antibiotic
European Investment Bank and BioVersys sign a financing agreement of up to €20 million to facilitate the development of new treatments against life-threatening resistant bacterial infections. The venture debt loan is financed under the Infectious Diseases Finance Facility set up as part...
Source: pharmiweb.com